Disparate and Alarming Impact of Gastrointestinal Cancers in Young Adult Patients.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 21 05 2020
accepted: 11 07 2020
pubmed: 3 8 2020
medline: 6 5 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

The rise in the incidence of gastric cancer (GC) and colorectal cancer (CRC) in young adults (YA) remains unexplained. We aim to identify differences in these malignancies between YA and older patients. We retrospectively analyzed the California Cancer Registry for all GC and CRC cases from 2000 to 2012. Pearson's Chi square analysis and stepwise regression model with backward elimination were used to analyze differences in demographic, clinical, and histopathologic features, and log-rank test to compare survival between young (≤ 40 years) and older adults (41-90 years) with GC or CRC, separately. We analyzed 19,368 cases of GC and 117,415 cases of CRC. YA accounted for 4.6% of GC (n = 883) and 2.8% of CRC (n = 3273) patients. Compared with older patients, YA were more likely to be Hispanic (P < 0.0001) and have poorly differentiated (P < 0.0001), higher histologic grade (P < 0.0001), and signet ring features (P < 0.0001). Synchronous peritoneal metastases were more common in YA patients (32.1% vs. 14.1% GC, 8.8% vs. 5.4% CRC, P < 0.0001). The 5-year overall survival (OS) of YA with CRC or GC was longer than that of older patients with the same stage of malignancy; except YA with stage I GC, who demonstrated poor OS and disease-specific survival (DSS) (65.1% and 67.9%, respectively) which were significantly worse than those of adults aged 41-49 years (70.7% and 76.2%, respectively) and 50-64 years (69.1% and 78.1%, respectively). YA with GC or CRC have distinctly worse clinical and histopathologic features compared with older patients and are disproportionately of Hispanic ethnicity. These results contribute to improving understanding of younger versus older GI cancer patients.

Sections du résumé

BACKGROUND BACKGROUND
The rise in the incidence of gastric cancer (GC) and colorectal cancer (CRC) in young adults (YA) remains unexplained. We aim to identify differences in these malignancies between YA and older patients.
PATIENTS AND METHODS METHODS
We retrospectively analyzed the California Cancer Registry for all GC and CRC cases from 2000 to 2012. Pearson's Chi square analysis and stepwise regression model with backward elimination were used to analyze differences in demographic, clinical, and histopathologic features, and log-rank test to compare survival between young (≤ 40 years) and older adults (41-90 years) with GC or CRC, separately.
RESULTS RESULTS
We analyzed 19,368 cases of GC and 117,415 cases of CRC. YA accounted for 4.6% of GC (n = 883) and 2.8% of CRC (n = 3273) patients. Compared with older patients, YA were more likely to be Hispanic (P < 0.0001) and have poorly differentiated (P < 0.0001), higher histologic grade (P < 0.0001), and signet ring features (P < 0.0001). Synchronous peritoneal metastases were more common in YA patients (32.1% vs. 14.1% GC, 8.8% vs. 5.4% CRC, P < 0.0001). The 5-year overall survival (OS) of YA with CRC or GC was longer than that of older patients with the same stage of malignancy; except YA with stage I GC, who demonstrated poor OS and disease-specific survival (DSS) (65.1% and 67.9%, respectively) which were significantly worse than those of adults aged 41-49 years (70.7% and 76.2%, respectively) and 50-64 years (69.1% and 78.1%, respectively).
CONCLUSIONS CONCLUSIONS
YA with GC or CRC have distinctly worse clinical and histopathologic features compared with older patients and are disproportionately of Hispanic ethnicity. These results contribute to improving understanding of younger versus older GI cancer patients.

Identifiants

pubmed: 32740736
doi: 10.1245/s10434-020-08969-7
pii: 10.1245/s10434-020-08969-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

785-796

Références

Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019. https://doi.org/10.1016/s2468-2667(18)30267-6 .
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2018.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Lyon, France: International Agency for Research on Cancer; 2013
Anderson WF, Camargo MC, Fraumeni JF, Jr., Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010. https://doi.org/10.1001/jama.2010.496 .
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015. https://doi.org/10.3322/caac.21262 .
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016. https://doi.org/10.3322/caac.21332 .
Phillips KA, Liang SY, Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007. https://doi.org/10.1097/01.mlr.0000246612.35245.21 .
Merchant SJ, Kim J, Choi AH, Sun V, Chao J, Nelson R. A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer. 2017. https://doi.org/10.1007/s10120-016-0603-7 .
Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009. https://doi.org/10.1158/1055-9965.Epi-09-0186 .
Cress RD, Morris C, Ellison GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001. Cancer. 2006. https://doi.org/10.1002/cncr.22011 .
O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003;69(10):866–872.
pubmed: 14570365
Goel A, Nagasaka T, Spiegel J, Meyer R, Lichliter WE, Boland CR. Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer. Clin Gastroenterol Hepatol. 2010. https://doi.org/10.1016/j.cgh.2010.06.030 .
Kwak HW, Choi IJ, Kim CG, et al. Individual having a parent with early-onset gastric cancer may need screening at younger age. World J Gastroenterol. 2015. https://doi.org/10.3748/wjg.v21.i15.4592 .
Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010. https://doi.org/10.1177/1066896910366463 .
Rona KA, Schwameis K, Zehetner J, et al. Gastric cancer in the young: an advanced disease with poor prognostic features. J Surg Oncol. Mar 2017. https://doi.org/10.1002/jso.24533 .
You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012. https://doi.org/10.1001/archinternmed.2011.602 .
Chang DT, Pai RK, Rybicki LA, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012. https://doi.org/10.1038/modpathol.2012.61 .
Bergquist JR, Leiting JL, Habermann EB, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019. https://doi.org/10.1016/j.surg.2019.04.036 .
Skierucha M, Milne AN, Offerhaus GJ, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol. 2016. https://doi.org/10.3748/wjg.v22.i8.2460 .
Milne AN, Sitarz R, Carvalho R, Carneiro F, Offerhaus GJ. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med. 2007. https://doi.org/10.2174/156652407779940503 .
Chan TL, Curtis LC, Leung SY, et al. Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene. 2001. https://doi.org/10.1038/sj.onc.1204653 .
Boardman LA, Johnson RA, Petersen GM, et al. Higher frequency of diploidy in young-onset microsatellite-stable colorectal cancer. Clin Cancer Res. 2007. https://doi.org/10.1158/1078-0432.Ccr-06-2739 .
Jacobs D, Zhu R, Luo J, et al. Defining early-onset colon and rectal cancers. Front Oncol. 2018. https://doi.org/10.3389/fonc.2018.00504 .
Teng A, Lee DY, Cai J, Patel SS, Bilchik AJ, Goldfarb MR. Patterns and outcomes of colorectal cancer in adolescents and young adults. J Surg Res. 2016. https://doi.org/10.1016/j.jss.2016.05.036 .
Khan SA, Morris M, Idrees K, et al. Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg. 2016. https://doi.org/10.1016/j.jpedsurg.2016.07.015 .
Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000. https://doi.org/10.1056/nejm200001133420201 .
Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016. https://doi.org/10.1002/cncr.29716 .
Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer. 2012. https://doi.org/10.1016/j.currproblcancer.2012.03.007 .
Parikh-Patel A, Morris CR, Kizer KW. Disparities in quality of cancer care: the role of health insurance and population demographics. Medicine (Baltimore). 2017. https://doi.org/10.1097/md.0000000000009125 .
Edge SB, American Joint Committee on C. AJCC cancer staging manual. New York: Springer; 2010.
Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001. https://doi.org/10.1023/a:1011240019516 .
Yang J SC, Harrati A, Clarke C, Keegan T, Gomez S. Developing an area-based socioeconomic measure from American Community Survey data. Fremont, California: Cancer Prevention Institute of California; 2014.
Medicode (Firm). ICD-9-CM: International classification of diseases, 9th revision, clinical modification. Salt Lake City, Utah: Medicode; 1996.
Koblinski J, Jandova J, Nfonsam V. Disparities in incidence of early- and late-onset colorectal cancer between Hispanics and Whites: a 10-year SEER database study. Am J Surg. 2018. https://doi.org/10.1016/j.amjsurg.2017.03.035 .
Rahman R, Schmaltz C, Jackson CS, Simoes EJ, Jackson-Thompson J, Ibdah JA. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med. 2015. https://doi.org/10.1002/cam4.560 .
Wang ZK, Lin JX, Li P, et al. Higher risk of lymph node metastasis in young patients with early gastric cancer. J Cancer. 2019. https://doi.org/10.7150/jca.30260 .
Qiu MZ, Wang ZQ, Zhang DS, et al. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol. 2011. https://doi.org/10.1007/s13277-010-0145-2 .
Chen YC, Fang WL, Wang RF, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016. https://doi.org/10.1007/s12253-015-9996-6 .
Holowatyj AN, Ulrich CM, Lewis MA. Racial/ethnic patterns of young-onset noncardia gastric cancer. Cancer Prev Res (Phila). 2019. https://doi.org/10.1158/1940-6207.Capr-19-0200 .
Tsai JH, Jeng YM, Chen KH, Lee CH, Yuan CT, Liau JY. An Integrative morphomolecular classification system of gastric carcinoma with distinct clinical outcomes. Am J Surg Pathol. 2020. https://doi.org/10.1097/pas.0000000000001521 .
Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014. https://doi.org/10.1038/nature13480 .
Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015. https://doi.org/10.1038/nm.3967 .
Willauer AN, Liu Y, Pereira AAL, et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer. 2019. https://doi.org/10.1002/cncr.31994 .
Soldevilla B, Carretero-Puche C, Gomez-Lopez G, et al. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications. Eur J Cancer. 2019. https://doi.org/10.1016/j.ejca.2019.09.008 .
Hawkins NJ, Tomlinson I, Meagher A, Ward RL. Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br J Cancer. 2001. https://doi.org/10.1054/bjoc.2000.1554 .
Banerjea A, Hands RE, Powar MP, Bustin SA, Dorudi S. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence. Colorectal Dis. 2009. https://doi.org/10.1111/j.1463-1318.2008.01639.x .
Cavestro GM, Mannucci A, Zuppardo RA, Di Leo M, Stoffel E, Tonon G. Early onset sporadic colorectal cancer: worrisome trends and oncogenic features. Dig Liver Dis. 2018. https://doi.org/10.1016/j.dld.2018.02.009 .
Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010. https://doi.org/10.1053/j.gastro.2009.12.065 .
Migliore L, Migheli F, Spisni R, Coppede F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol. 2011. https://doi.org/10.1155/2011/792362 .
Lin JK, Chang SC, Yang YC, Li AF. Loss of heterozygosity and DNA aneuploidy in colorectal adenocarcinoma. Ann Surg Oncol. 2003. https://doi.org/10.1245/aso.2003.12.014 .
Setia N, Wang C, Lager A. Morphologic and molecular analysis of early-onset gastroesophageal adenocarcinomas. J Clin Onc. 2020; 38: 15 (Abstract 4547).
Woo Y, Goldner B, Ituarte P, et al. Lymphadenectomy with optimum of 29 lymph nodes retrieved associated with improved survival in advanced gastric cancer: a 25,000-patient international database study. J Am Coll Surg. 2017. https://doi.org/10.1016/j.jamcollsurg.2016.12.015 .
Lee KS, Oh DK, Han MA, et al. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat. 2011. https://doi.org/10.4143/crt.2011.43.2.83 .
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21457 .

Auteurs

Amir Khan (A)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Philip H G Ituarte (PHG)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Mustafa Raoof (M)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Laleh Melstrom (L)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Haiqing Li (H)

Department of Computational Quantitative Medicine, Center for Informatics, Beckman Research Institute of City of Hope, Duarte, CA, USA.

Yate-Ching Yuan (YC)

Department of Computational Quantitative Medicine, Center for Informatics, Beckman Research Institute of City of Hope, Duarte, CA, USA.

Lily Lai (L)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

I Benjamin Paz (I)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Ajay Goel (A)

Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA, USA.

Yuman Fong (Y)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA.

Yanghee Woo (Y)

Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA. ywoo@coh.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH